Join
Live feed
·
NEWSReleasevia Quantisnow
Wellgistics Health Inc. logo

Wellgistics Targets $70B Market Breakthrough Addressing Ozempic / GLP-1 Muscle Loss with Forzet(TM)

ByQuantisnow·Wall Street's wire, on your screen.
WGRX· Wellgistics Health Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track WGRX (Wellgistics Health Inc.) and more on Quantisnow.